A limiting factor for the progress of radionuclide-based cancer diagnostics and therapy

Author： Tolmachev Vladimir   Carlsson Jörgen   Lundqvist Hans  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.43, Iss.3, 2004-04, pp. : 264-275

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Radionuclide Therapy of Cancer with Radiolabeled Antibodies

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 7, Iss. 3, 2007-05 ,pp. : 335-343

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in Cancer Gene Therapy

By Kouraklis Gregory  

Acta Oncologica, Vol. 38, Iss. 6, 1999-09 ,pp. : 675-683

Informa Healthcare

Access to resources Recommend Favorite

Cancer Nanotechnology - Prospects for Cancer Diagnostics and Therapy

By  

Current Cancer Therapy Reviews, Vol. 5, Iss. 2, 2009-01 ,pp. : 80-88

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Therapy for Cancer: Integrating Diagnostics and Therapeutics

By Jeffrey S. Ross  

American Journal of Cancer, Vol. 3, Iss. 4, 2004-01 ,pp. : 205-214

Adis International

Access to resources Recommend Favorite

Progress in systemic therapy for breast cancer: an overview and perspectives

By Piccart M.J.   Cardoso F.  

EJC Supplements, Vol. 1, Iss. 2, 2003-09 ,pp. : 56-69

Elsevier

Access to resources Recommend Favorite